Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of IBI311 in inactive thyroid eye disease and is currently recruiting. Sponsor: Innovent Biologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• IBI311

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Thyroid Eye Disease | Phase 3 | Status: RECRUITING